Likewise, it was demonstrated by actualizing high throughput screening in-vitro framework that the drug fenbendazole is successful, not just against standard non-small cell lung cancer, NSCLC, yet in addition against the KRAS-mutant malignancy which seems, by all accounts, aggressive, barely accessible by chemotherapy and
More
Drug delivery is not as easy as simply getting the right drug
Anticipated to surpass the US$ 20 Billion mark in 2019, generic oncology
Likewise, it was demonstrated by actualizing high throughput screening in-vitro framework that the drug fenbendazole is successful, not just against
More
The cases of mesothelioma have been increasing and cause-oriented groups have been lobbying to get companies to properly dispose of
MoreAnticipated to surpass the US$ 20 Billion mark in 2019, generic oncology drugs will witness an increased demand in the
MoreDrug delivery is not as easy as simply getting the right drug into contact with the right cells. We need
More
Liver cancer is the second most common cause of cancer related death worldwide, and hepatocellular carcinoma (HCC) accounts for more
More
For a cancer patient, the biopsy is a way of life. During regular screenings after the initial cancer diagnosis, and
More
In the late 1990s, industry experts predicted the pharmaceutical industry would increasingly struggle to fulfill the world’s medical needs. Aging
More
UNSW chemical engineers have synthesised a new iron oxide nanoparticle that delivers cancer drugs to cells while simultaneously monitoring the
More
[column]A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced
More
Cancer has become a foremost cause of death around the world. Cancer is an extremely complex disease to understand because
More
